← Leaderboards
Stephen P Massia
University Of Washington
$1,106,045
Attributed
$1,106,045
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,106,045 · 3
By mechanism
R01$607,500 · 1
K02$493,637 · 1
P41$4,908 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Antonios G. Mikos$14,067,698
- Thomas A Reh$17,988,348
- Charles E Murry$34,391,211
- Stuart Shankland$30,345,727
- Stephanie J Bryant$9,910,519
Others in their field
Top investigators on “Biomaterial Development /Preparation”
- Joyce Carol Niland · City Of Hope/Beckman Research Institute$14,068,948
- Robert Jay Greenberg · Second Sight Medical Products, Inc.$13,197,584
- Buddy D Ratner · University Of Washington$9,440,722
- Duncan J Maitland · Texas Engineering Experiment Station$5,571,704
- Marcos Intaglietta · University Of California San Diego$5,417,160
- Elliot Chaikof · Beth Israel Deaconess Medical Center$5,029,412
Research focus
Biomaterial Development /PreparationBioengineering /Biomedical EngineeringMedical Implant ScienceDrug Delivery SystemsBiomaterial CompatibilityImplantLaboratory RatBiomaterial Interface InteractionTissue EngineeringGene Delivery SystemBiomaterialsCardiovascular SystemPolyethylenesPolymersRegenerationRestenosisSkinSlow Release DrugTissue Support FrameTransplant RejectionAngiogenesisVascular EndotheliumBiomedical ResourceBlood Vessel Transplantation
Grant awards (11)
Engineered Biomaterials for Cardiovascular Implants$101,250
K02 · FY2005 · HL
Engineered Biomaterials for Cardiovascular Implants$101,250
K02 · FY2004 · HL
Engineered Biomaterials for Cardiovascular Implants$99,928
K02 · FY2003 · HL
LOCAL THERAPY TO LIMIT VASCULAR GRAFT HYPERPLASIA$202,500
R01 · FY2002 · HL
Engineered Biomaterials for Cardiovascular Implants$97,017
K02 · FY2002 · HL
SURFACE MODIFICATION USING DEXTRAN FOR IMPROVED BIOCOMPATIBILITY: CELL ADHESION$0
P41 · FY2002 · RR
LOCAL THERAPY TO LIMIT VASCULAR GRAFT HYPERPLASIA$202,500
R01 · FY2001 · HL
Engineered Biomaterials for Cardiovascular Implants$94,192
K02 · FY2001 · HL
SURFACE MODIFICATION USING DEXTRAN FOR IMPROVED BIOCOMPATIBILITY: CELL ADHESION$0
P41 · FY2001 · RR
LOCAL THERAPY TO LIMIT VASCULAR GRAFT HYPERPLASIA$202,500
R01 · FY2000 · HL
SURFACE MODIFICATION USING DEXTRAN FOR IMPROVED BIOCOMPATIBILITY: CELL ADHESION$4,908
P41 · FY2000 · RR